These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19958159)

  • 41. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
    Zhang S; Kong WJ
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
    Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H
    Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer.
    Marsit CJ; Houseman EA; Schned AR; Karagas MR; Kelsey KT
    Carcinogenesis; 2007 Aug; 28(8):1745-51. PubMed ID: 17522068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: a prospective, two-center validation study.
    Vinci S; Giannarini G; Selli C; Kuncova J; Villari D; Valent F; Orlando C
    Urol Oncol; 2011; 29(2):150-6. PubMed ID: 19272801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
    Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
    Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
    Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
    J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
    Tang X; Khuri FR; Lee JJ; Kemp BL; Liu D; Hong WK; Mao L
    J Natl Cancer Inst; 2000 Sep; 92(18):1511-6. PubMed ID: 10995806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.
    Beukers W; Hercegovac A; Vermeij M; Kandimalla R; Blok AC; van der Aa MM; Zwarthoff EC; Zuiverloon TC
    J Urol; 2013 Jul; 190(1):311-6. PubMed ID: 23369722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: Promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2004 Oct; 35(10):1266-71. PubMed ID: 15492995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.
    Katzenellenbogen RA; Baylin SB; Herman JG
    Blood; 1999 Jun; 93(12):4347-53. PubMed ID: 10361133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer.
    Habuchi T; Takahashi T; Kakinuma H; Wang L; Tsuchiya N; Satoh S; Akao T; Sato K; Ogawa O; Knowles MA; Kato T
    Oncogene; 2001 Jan; 20(4):531-7. PubMed ID: 11313984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGFBR3 co-downregulated with GATA3 is associated with methylation of the GATA3 gene in bladder urothelial carcinoma.
    Liu XL; Xue BX; Lei Z; Yang DR; Zhang QC; Shan YX; Zhang HT
    Anat Rec (Hoboken); 2013 Nov; 296(11):1717-23. PubMed ID: 24124001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.
    Chim CS; Fung TK; Wong KF; Lau JS; Liang R
    J Hum Genet; 2006; 51(9):832-838. PubMed ID: 16897188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.